news banner 2107 2

News

Print

Self-testing helps combat HIV in adolescents

on .

WHO

Today only half of people living with HIV are aware of their status. This "testing gap", coupled with the importance of early treatment for HIV, is driving interest in of the role of self-testing for HIV.


Concerns about confidentiality and privacy are one of the key barriers to HIV testing services for adolescents (aged 10-19), as expressed by this young woman in Malawi. However, recent studies on the use of HIV self-tests suggest that the availability of a simple and discreet way to know their status themselves may be one of the keys to dramatically increasing the number of adolescents who take a test and go on to access support and further HIV testing, prevention, treatment and care.

Print

Scientists Call for Improved Health Service Delivery through Quality Research and Collaboration

on .

asm2015

For Malawi to register remarkable improvement in the health delivery service, there is need for closer collaboration  between local and international health research institutions to  ensure  that the research being done is of high quality a development which can influence policy formulation.


The remarks were made by the Associate Director for the Malawi Liverpool Wellcome Trust MLW Dr Wilson Mandala during the opening of the 2015 annual scientific meeting being held at Makokola Retreat in Mangochi.


The annual scientific meeting which Malawi is hosting for the fifth time brings together scientists from The Malawi Liverpool Welcome Trust Clinical Research Programme, College of Medicine and the Wellcome Trust Liverpool Glasgow Centre for Global Health Research in Liverpool and other international research institutions.

Print

MLW in a Study to Improve Pneumonia Vaccines

on .

pneumoniapicThe Nurse Cordinator for the study, Roseline Nyirenda briefing the media about the study

The Malawi-Liverpool-Wellcome-Trust Clinical Research Programme (MLW has embarked on a study called “Pneumococcal Carriage in Vulnerable Populations in Africa” (PCVPA) which aims at improving pneumonia vaccines for Malawi and in some parts of Africa.

 

The pneumonia vaccine, called PCV13, has been given to newborns in Malawi since November 2011. This vaccine prevents disease caused by a germ called the pneumococcus which is found in the nose of many healthy people without causing any problem but in a small number of people this germ can cause pneumonia and meningitis.